5904-85-8 Usage
General Description
2-{[4-(1,1,3,3-Tetramethylbutyl)phenoxy]methyl}oxirane is a chemical compound that belongs to the class of epoxides. It contains a phenyl group attached to an oxirane ring, with a tetramethylbutyl substituent on the phenyl ring. 2-{[4-(1,1,3,3-TETRAMETHYLBUTYL)PHENOXY]METHYL}OXIRANE is commonly used as a reactive diluent in epoxy resins, which are widely used in industrial and commercial applications such as coatings, adhesives, and composites. It acts as a cross-linking agent in these resins, improving their mechanical and chemical properties. Additionally, it can also be used as a raw material in the synthesis of other chemicals and materials. However, it is important to handle this compound with care, as it may pose risks to human health and the environment if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 5904-85-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,0 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5904-85:
(6*5)+(5*9)+(4*0)+(3*4)+(2*8)+(1*5)=108
108 % 10 = 8
So 5904-85-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H26O2/c1-16(2,3)12-17(4,5)13-6-8-14(9-7-13)18-10-15-11-19-15/h6-9,15H,10-12H2,1-5H3/t15-/m0/s1
5904-85-8Relevant articles and documents
SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
-
Page/Page column 38, (2010/04/23)
The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
